Indian Journal of Thoracic and Cardiovascular Surgery, Год журнала: 2024, Номер 40(6), С. 696 - 706
Опубликована: Июль 2, 2024
Язык: Английский
Indian Journal of Thoracic and Cardiovascular Surgery, Год журнала: 2024, Номер 40(6), С. 696 - 706
Опубликована: Июль 2, 2024
Язык: Английский
JACC Asia, Год журнала: 2025, Номер 5(2), С. 270 - 272
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0EuroIntervention, Год журнала: 2025, Номер 21(5), С. e282 - e284
Опубликована: Фев. 24, 2025
Язык: Английский
Процитировано
0Clinical Research in Cardiology, Год журнала: 2025, Номер unknown
Опубликована: Март 10, 2025
Heavy calcifications in severe aortic stenosis (AS) pose a major challenge patients undergoing transcatheter valve replacement (TAVR). Only few studies have addressed the performance of different heart valves (THV) this subgroup patients. We aimed to investigate outcomes self-expanding Medtronic CoreValve Evolut frame and balloon-expandable Edwards SAPIEN-3/3 Ultra THV challenging patient population. This was multicenter registry including total 1513 with heavily calcified AS TAVR. The primary endpoint incidence degree paravalvular leak (PVL) after Secondary endpoints were post-implant hemodynamics as well clinical according VARC-3 definitions. R but not PRO showed significantly higher rates PVL compared (44.8% vs. 29.5% for mild PVL, p < 0.001), while there no significant difference ≥ moderate between both groups (p = 0.399). superior group. These findings confirmed propensity score-matched analysis. There differences regarding short-term permanent pacemaker implantation all-cause mortality three groups. In severely AS, lower than R. platform had system.
Язык: Английский
Процитировано
0The American Journal of the Medical Sciences, Год журнала: 2025, Номер unknown
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Cardiovascular revascularization medicine, Год журнала: 2025, Номер unknown
Опубликована: Май 1, 2025
Язык: Английский
Процитировано
0КАРДИОЛОГИЯ УЗБЕКИСТАНА, Год журнала: 2023, Номер 16(24), С. 2999 - 3012
Опубликована: Окт. 23, 2023
Язык: Английский
Процитировано
8Journal of Cardiovascular Development and Disease, Год журнала: 2023, Номер 10(5), С. 187 - 187
Опубликована: Апрель 23, 2023
Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR) is emerging as an effective treatment for patients with symptomatically failing bioprosthetic valves and a high prohibitive surgical risk; longer life expectancy has led to higher demand these reinterventions due the increased possibilities of outliving valve’s durability. Coronary obstruction most feared complication valve-in-valve TAVR; it rare but life-threatening occurs frequently at left coronary artery ostium. Accurate pre-procedural planning, mainly based on cardiac computed tomography, crucial determining feasibility ViV TAVR assessing anticipated risk eventual need protection measures. Intraprocedurally, root selective angiography are useful evaluating anatomic relationship between ostia; transesophageal echocardiographic real-time monitoring flow color Doppler pulsed-wave valuable tool that allows determination patency detection asymptomatic obstructions. Because developing delayed obstruction, close postprocedural obstructions advisable. CT simulations TAVR, 3D printing models, fusion imaging represent future directions may help provide personalized lifetime strategy tailored approach each patient, potentially minimizing complications improving outcomes.
Язык: Английский
Процитировано
7КАРДИОЛОГИЯ УЗБЕКИСТАНА, Год журнала: 2024, Номер 17(22), С. 2575 - 2595
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
2EuroIntervention, Год журнала: 2023, Номер 20(1), С. 95 - 103
Опубликована: Дек. 29, 2023
Midterm comparative analyses of the latest iterations most used Evolut and SAPIEN platforms for transcatheter aortic valve implantation (TAVI) are lacking.
Язык: Английский
Процитировано
4КАРДИОЛОГИЯ УЗБЕКИСТАНА, Год журнала: 2024, Номер 17(3), С. 402 - 404
Опубликована: Фев. 1, 2024
Язык: Английский
Процитировано
1